Evidence map›Paper›PMID 31502858›Full record

ReviewThe British journal of radiology2019

Emerging techniques in atherosclerosis imaging.

Maaz Bj Syed, Alexander J Fletcher, Rachael O Forsythe, Jakub Kaczynski, David E Newby, Marc R Dweck, Edwin Jr van Beek

Abstract readReview
In one paragraph

Review in The British journal of radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Aortic Atherosclerosis: An Updated Review of Current Guidelines and Management Approach-A Literature Review.The International journal of angiology : official publication of the International College of Angiology, Inc · 2026
    Article
  3. Atherosclerosis: A Pathologist's Perspective.Journal of cardiovascular development and disease · 2026
    Review
  4. Article
  5. Review
  6. Diagnostics (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Nanomedicines for cardiovascular disease.Nature cardiovascular research · 2023
    Review
  16. Review
  17. Diagnostics of atherosclerosis: Overview of the existing methods.Frontiers in cardiovascular medicine · 2023
    Review
  18. Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?International journal of molecular sciences · 2022
    Review
  19. Quantifying sodium [EJNMMI research · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maaz Bj SyedBritish Heart Foundation Centre of Cardiovascular Science.
Alexander J FletcherBritish Heart Foundation Centre of Cardiovascular Science.
Rachael O ForsytheBritish Heart Foundation Centre of Cardiovascular Science.
Jakub KaczynskiBritish Heart Foundation Centre of Cardiovascular Science.
David E NewbyBritish Heart Foundation Centre of Cardiovascular Science.
Marc R DweckBritish Heart Foundation Centre of Cardiovascular Science.
Edwin Jr van BeekBritish Heart Foundation Centre of Cardiovascular Science.

Funding

British Heart Foundation CH/09/002/26360British Heart Foundation FS/14/78/31020British Heart Foundation FS/16/19/31982British Heart Foundation FS/17/50/33061British Heart Foundation FS/18/31/33676British Heart Foundation RG/16/10/32375Chief Scientist Office ETM/365Medical Research Council G0701127Medical Research Council MC_PC_12040
6 · The paper itself

Abstract

Atherosclerosis is a chronic immunomodulated disease that affects multiple vascular beds and results in a significant worldwide disease burden. Conventional imaging modalities focus on the morphological features of atherosclerotic disease such as the degree of stenosis caused by a lesion. Modern CT, MR and positron emission tomography scanners have seen significant improvements in the rapidity of image acquisition and spatial resolution. This has increased the scope for the clinical application of these modalities. Multimodality imaging can improve cardiovascular risk prediction by informing on the constituency and metabolic processes within the vessel wall. Specific disease processes can be targeted using novel biological tracers and "smart" contrast agents. These approaches have the potential to inform clinicians of the metabolic state of atherosclerotic plaque. This review will provide an overview of current imaging techniques for the imaging of atherosclerosis and how various modalities can provide information that enhances the depiction of basic morphology.

Indexed as

Aortic DiseasesAtherosclerosisCarotid Artery DiseasesContrast MediaCoronary DiseaseDiagnostic ImagingHumansMagnetic Resonance AngiographyMagnetic Resonance SpectroscopyMagnetite NanoparticlesMolecular ImagingSpectrophotometry, InfraredTomography, Optical CoherenceTomography, X-Ray ComputedUltrasonography, InterventionalVascular CalcificationContrast MediaMagnetite Nanoparticles

Identifiers

PMID31502858
PMCPMC6849665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.